CN Patent

CN101732319A — 含有盐酸兰地洛尔活性成分的注射用药物组合物及其制备方法

Assigned to KUNMING JIDA PHARMACEUTICAL CO Ltd · Expires 2010-06-16 · 16y expired

What this patent protects

本发明公开了一种含有盐酸兰地洛尔活性成分的注射用药物组合物，本发明的注射用盐酸兰地洛尔冻干制剂具有良好的药物稳定性，临床使用和运输都很方便，该制剂专供临床手术时心动过速性心律失常(心房纤维性颤动、心房扑动及窦性心动过速)的紧急治疗，本发明提供了制备方法。

USPTO Abstract

本发明公开了一种含有盐酸兰地洛尔活性成分的注射用药物组合物，本发明的注射用盐酸兰地洛尔冻干制剂具有良好的药物稳定性，临床使用和运输都很方便，该制剂专供临床手术时心动过速性心律失常(心房纤维性颤动、心房扑动及窦性心动过速)的紧急治疗，本发明提供了制备方法。

Drugs covered by this patent

landiolol-hydrochloride (LANDIOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN101732319A
Jurisdiction: CN
Classification: —
Expires: 2010-06-16
Drug substance claim: No
Drug product claim: No
Assignee: KUNMING JIDA PHARMACEUTICAL CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.